Medical assessment of adverse health outcomes in long-term survivors of childhood cancer

  • 0Late Effects Study Group and Outpatient Clinic/Polikliniek Late Effecten Kindertumoren (PLEK), Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands.

|

|

Summary

This summary is machine-generated.

Childhood cancer survivors face significant long-term health issues, with many experiencing multiple adverse events by young adulthood, especially after radiotherapy. Lifelong medical surveillance is crucial for managing this burden of disease.

Area Of Science

  • Pediatric Oncology
  • Cancer Survivorship Research
  • Long-Term Health Outcomes

Background

  • Childhood cancer survival rates have improved, but survivors often experience multiple treatment-related complications.
  • Previous studies primarily focused on single late effects in childhood cancer survivors.
  • A comprehensive assessment of the total burden of adverse health outcomes is needed.

Purpose Of The Study

  • To evaluate the overall burden of clinical and subclinical adverse events in a large cohort of childhood cancer survivors.
  • To analyze long-term medical follow-up data for a comprehensive understanding of late effects.
  • To identify the prevalence and severity of adverse events in young adult survivors.

Main Methods

  • Retrospective cohort study of 1362 five-year childhood cancer survivors.
  • Medical assessments conducted at a dedicated late-effects clinic.
  • Standardized grading of adverse events for severity up to January 2004.

Main Results

  • High or severe burden of adverse events observed in 55% of radiotherapy survivors and 15% of chemotherapy survivors.
  • Bone tumor survivors had the highest incidence (64%) of severe adverse events.
  • Nearly 75% of survivors reported at least one adverse event, with 24.6% reporting five or more.

Conclusions

  • A significant proportion of childhood cancer survivors experience a high or severe burden of disease in young adulthood.
  • Radiotherapy is strongly associated with an increased risk of severe adverse events.
  • Risk-stratified, lifelong medical surveillance is essential for managing the long-term health of childhood cancer survivors.

Related Concept Videos